Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Telocytes in the scalp may help with skin regeneration and maintenance.

A boy with toxic shock syndrome had severe heart rhythm problems but recovered with treatment.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Inhibiting certain brain neurons may reduce pain and anxiety in trigeminal neuralgia.

A new amino acid derivative, ATS, improves hair texture and moisture, making it easier to straighten curly hair.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Trichoscopy helped diagnose and treat a child's fungal scalp infection by spotting specific hair shapes.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Facial trichostasis spinulosa is a chronic condition with significant cosmetic impact, especially in young women.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Calotropis gigantea and Tridax procumbens extracts reduce inflammation more effectively than low-dose Ibuprofen.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.